ArticleInternational journal of biological macromolecules2021

Repurposing clinically approved drugs for COVID-19 treatment targeting SARS-CoV-2 papain-like protease.

Yunxia Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.